Zentalis Pharma Files 2025 Proxy Statement
Ticker: ZNTL · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1725160
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Zentalis proxy out - exec pay & annual meeting details for shareholders.
AI Summary
Zentalis Pharmaceuticals, Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation and annual meeting information for the fiscal year ending December 31, 2024. The filing includes details on compensation for key individuals such as EastlandMember and BlackwellMember, and outlines the company's corporate governance practices. The annual meeting is scheduled for June 17, 2025.
Why It Matters
This filing provides shareholders with crucial information regarding executive pay and company governance, enabling informed voting decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but can sometimes reveal compensation issues or governance concerns that impact investor confidence.
Key Players & Entities
- Zentalis Pharmaceuticals, Inc. (company) — Filer of the DEF 14A
- EastlandMember (person) — Executive compensation recipient
- BlackwellMember (person) — Executive compensation recipient
- June 17, 2025 (date) — Date of the annual meeting
- April 30, 2025 (date) — Filing date of the DEF 14A
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding executive compensation, corporate governance, and details for the upcoming annual meeting scheduled for June 17, 2025.
Who are some of the individuals whose compensation is detailed in this filing?
The filing references compensation details for individuals identified as zntl:EastlandMember and zntl:BlackwellMember.
When is Zentalis Pharmaceuticals' fiscal year end?
Zentalis Pharmaceuticals' fiscal year ends on December 31.
What is the filing date of this DEF 14A?
This DEF 14A filing was made on April 30, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 by EastlandMember regarding Zentalis Pharmaceuticals, Inc. (ZNTL).